Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 November 2020 | Story Thabo Kessah | Photo Thabo Kessah
Prof Pearl Sithole acknowledged the role played by the Afromontane Research Unit in securing mountain-to-mountain research funding from the US Embassy and Consulates in SA.

“This launch is an opportunity to reflect on the strategic significance of the partnership between our two universities and the long-standing relationship that academics at the two institutions have enjoyed.” 

These were the words of appreciation from the University of the Free State Vice-Rector: Research, Innovation and Internationalisation, Prof Corli Witthuhn, during the virtual launch of the Mountain-to-Mountain collaboration project between the University of the Free State and the Appalachian State University in the United States held on 10 November 2020. The R8 million project is funded by the US Embassy and Consulates in South Africa and will run over two academic years.

Prof Witthuhn also stated that the project would further strengthen the UFS strategy for internationalisation. “This collaboration has grown organically in the last decade to become one of the UFS flagships in international collaborations. With the support of this grant from the US Embassy and Consulates in South Africa, this long-standing and sustainable collaboration will be further strengthened,” she added.

New master’s programmes

In providing context to the Qwaqwa Campus’ research footprint, Campus Vice-Principal: Academic and Research, Prof Pearl Sithole, acknowledged the role played by the Afromontane Research Unit (ARU) under the leadership of its Director, Dr Ralph Clark, as well as all the faculties.

“In the Humanities, a lot is coming regarding the socio-ecosystems of the mountains. And in Education and Economic and Management Sciences, the scholarship of teaching and learning is promoted through blended skills, especially during this time of the pandemic. In the Natural and Agricultural Sciences, climate monitoring is one of the projects that has brought vibrancy to our campus,” she said.

Appalachian State University’s Associate Vice-Chancellor for International Education and Development, Prof Jesse Lutabingwa, mentioned that the collaboration would, among others, develop and offer a multi-disciplinary master’s degree in Mountain Studies on the Qwaqwa Campus, which will initially enrol seven to ten students. “In the subsequent years, we plan to increase this number to 15-20 students. We will also develop and offer a Community Development master’s degree with 10-12 students and up to 25 in subsequent years.”

Black women academics

Prof Lutabingwa, who is also the Project Director, revealed that doctoral students who are currently part of the University Staff Doctoral Project (USDP), will conduct at least three research projects focusing on social entrepreneurship, substance abuse, and rural transport monitoring in the Maloti-Drakensberg Mountains. “Also key to this collaboration is the leadership mentorship programme for black women academics who will at the end of the project produce three to five research papers,” Prof Lutabingwa added.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept